Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study

References

• Kaikkonen J, Nyyssönen K, Tuomainen TP, Ristonmaa U, Salonen JT. Determinants of plasma coenzyme Q10 in humans. FEBS Lett. 1999;443:163–166. doi:10.1016/s0014-5793(98)01712-89989597
   PubMed Web of Science ®Google Scholar
• Lockwood K, Moesgaard S, Yamamoto T, Folkers K. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochem Biophys Res Commun. 1995;212:172–177. doi:10.1006/bbrc.1995.19527612003
   PubMed Web of Science ®Google Scholar
• Soja AM, Mortensen SA. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. Mol Aspects Med. 1997;18:s159–s168. doi:10.1016/S0098-2997(97)00042-39266518
   PubMed Web of Science ®Google Scholar
• Ogasahara S, Engel AG, Frens D, Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA. 1989;86:2379–2382. doi:10.1073/pnas.86.7.23792928337
   PubMed Web of Science ®Google Scholar
• Folkers K, Langsjoen P, Willis R, et al. Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci USA. 1990;87:8931–8934. doi:10.1073/pnas.87.22.89312247468
   PubMed Web of Science ®Google Scholar
• Päivä H, Thelen KM, Van Coster R, et al. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clin Pharmacol Ther. 2005;78:60–68. doi:10.1016/j.clpt.2005.03.00616003294
   PubMed Web of Science ®Google Scholar
• Folkers K, Vadhanavikit S, Mortensen SA. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci USA. 1985;82:901–904. doi:10.1073/pnas.82.3.9013856239
   PubMed Web of Science ®Google Scholar
• Deichmann R, Lavie C, Andrews S, Ochsner J. Coenzyme q10 and statin-induced mitochondrial dysfunction. Ochsner J. 2010;10(1):16–21.21603349
   PubMedGoogle Scholar
• Derosa G, D’Angelo A, Franzetti IG, et al. Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment. J Clin Pharm Ther. 2009;34(3):267–276.19650249
   PubMed Web of Science ®Google Scholar
• Derosa G, Romano D, D’Angelo A, Maffioli P. Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. Atherosclerosis. 2015;239(1):87–92. doi:10.1016/j.atherosclerosis.2014.12.04325577665
   PubMed Web of Science ®Google Scholar
• Harper CR, Jacobsen TA. Evidence-based management of statin myopathy. Curr Atheroscler Rep. 2010;12(5):322–330. doi:10.1007/s11883-010-0120-920628837
   PubMed Web of Science ®Google Scholar
• Rosenson RS, Baker SK, Jacobson TA, Kopecky SL, Parker BA. The national lipid association’s muscle safety expert panel. an assessment by the statin muscle safety task force: 2014 update. J Clin Lipidol. 2014;8(3 Suppl):S58–S71. doi:10.1016/j.jacl.2014.03.00424793443
   PubMed Web of Science ®Google Scholar
• Chopra RK, Goldman R, Sinatra SP, Bhagavan HN. Relative bioavailability of Coenzyme Q10 formulations in human subjects. Int J Nutr Res. 1998;68:109–113.
   PubMed Web of Science ®Google Scholar
• Miles MV, Horn P, Miles L, Tang P, Steele P, DeGrauw T. Bioequivalence of coenzyme Q10 from over-the-counter supplements. Nutr Res. 2002;919–929. doi:10.1016/S0271-5317(02)00402-5
   Web of Science ®Google Scholar
• Zmitek J, Smidovnik A, Fir M, et al. Relative bioavailability of two forms of a novel water-soluble coenzyme Q10. Ann Nutr Metab. 2008;52(4):281–287. doi:10.1159/00012966118645245
   PubMed Web of Science ®Google Scholar
• Beg S, Javed S, Kohli K. Bioavailability enhancement of coenzyme Q10: an extensive review of patents. Recent Pat Drug Deliv Formul. 2010;4(3):245–255.20863275
   PubMedGoogle Scholar
• Klose S, Borner K. Enzymatische Bestimmung des Gesamtcholesterins mit dem [Enzymatic dosage of total cholesterolemia by Greiner Selective Analyzer (GSA II)]. J Clin Chem Clin Biochem. 1978;15:121–130.
   Google Scholar
• Wahlefeld AW. Triglycerides determination after enzymatic hydrolysis In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. 2nd ed. New York: Academic Press; 1974:18–31.
   Google Scholar
• Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345–1353. doi:10.1172/JCI10318213252080
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.4337382
   PubMed Web of Science ®Google Scholar
• Tang PH, Miles MV, DeGrauw A, Hershey A, Pesce A. HPLC analysis of reduced and oxidized coenzyme Q(10) in human plasma. Clin Chem. 2001;47(2):256–265.11159774
   PubMed Web of Science ®Google Scholar
• Winer BJ. Statistical Principles in Experimental Design. 2nd ed. New York (USA): McGraw-Hill; 1971.
   Google Scholar
• Qu H, Guo M, Chai H, Wang WT, Gao ZY, Shi DZ. Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7(19):e009835. doi:10.1161/JAHA.118.00852830371340
   PubMed Web of Science ®Google Scholar
• Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol. 2007;99:1409–1412. doi:10.1016/j.amjcard.2006.12.06317493470
   PubMed Web of Science ®Google Scholar
• Fedacko J, Pella D, Fedackova P, et al. Coenzyme Q10 and selenium in statin-associated myopathy treatment. Can J Physiol Pharmacol. 2013;91:165–170. doi:10.1139/cjpp-2012-011823458201
   PubMed Web of Science ®Google Scholar
• Skarlovnik A, Janic M, Lunder M, Turk M, Sabovic M. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med Sci Monit. 2014;20:2183–2188. doi:10.12659/MSM.89077725375075
   PubMed Web of Science ®Google Scholar
• Toth S, Sajty M, Pekarova T, et al. Addition of omega-3 fatty acid and coenzyme Q10 to statin therapy in patients with combined dyslipidemia. J Basic Clin Physiol Pharmacol. 2017;28:327–336. doi:10.1515/jbcpp-2016-014928541926
   PubMedGoogle Scholar
• Banach M, Serban C, Ursoniu S, et al. Statin therapy and plasma coenzyme Q10 concentrations: a systematic review and meta-analysis of placebo-controlled trials. Pharmacol Res. 2015;99:329–336. doi:10.1016/j.phrs.2015.07.00826192349
   PubMed Web of Science ®Google Scholar
• Qu H, Meng YY, Chai H, et al. The effect of statin treatment on circulating coenzyme Q10 concentrations: an updated meta-analysis of randomized controlled trials. Eur J Med Res. 2018;23(1):57. doi:10.1186/s40001-018-0306-030414615
   PubMed Web of Science ®Google Scholar
• Mikashinovich ZI, Belousova ES, Sarkisyan OG. Impairment of energy dependent processes in the muscle tissue as a pathogenetic mechanism of statin-induced myopathy. Bull Exp Biol Med. 2017;162:433–435. doi:10.1007/s10517-017-3633-128239789
   PubMed Web of Science ®Google Scholar
• Farsi F, Mohammadshahi M, Alavinejad P, Rezazadeh A, Zarei M, Engali KA. Functions of coenzyme Q10 supplementation on liver enzymes, markers of systemic inflammation, and adipokines in patients affected by nonalcoholic fatty liver disease: a double-blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr. 2016;35(4):346–353. doi:10.1080/07315724.2015.102105726156412
   PubMed Web of Science ®Google Scholar
• Keogh A, Fenton S, Leslie C, et al. Randomised double-blind, placebo-controlled trial of coenzyme Q, therapy in class II and III systolic heart failure. Heart Lung Circ. 2003;12(3):135–141.18705154
   PubMedGoogle Scholar
• Belardinelli R, Muçaj A, Lacalaprice F, et al. Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure. Biofactors. 2005;25(1–4):137–145.16873938
   PubMed Web of Science ®Google Scholar
• Marrs JC, Kostoff MD. Discontinuation of statins: what are the risks? Curr Atheroscler Rep. 2016;18(7):41. doi:10.1007/s11883-016-0596-z27221503
   PubMed Web of Science ®Google Scholar
• Young JM, Molyneux SL, Reinheimer AM, et al. Relationship between plasma coenzyme Q10, asymmetric dimethylarginine and arterial stiffness in patients with phenotypic or genotypic familial hypercholesterolemia on long-term statin therapy. Atherosclerosis. 2011;218(1):188–193. doi:10.1016/j.atherosclerosis.2011.04.03421640350
   PubMed Web of Science ®Google Scholar
• Larijani VN, Ahmadi N, Zeb I, Khan F, Flores F, Budoff M. Beneficial effects of aged garlic extract and coenzyme Q10 on vascular elasticity and endothelial function: the FAITH randomized clinical trial. Nutrition. 2013;29(1):71–75. doi:10.1016/j.nut.2012.03.01622858191
   PubMed Web of Science ®Google Scholar
• Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr. 2002;56(11):1137–1142. doi:10.1038/sj.ejcn.160146412428181
   PubMed Web of Science ®Google Scholar
• Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens. 1999;13(3):203–208.10204818
   PubMed Web of Science ®Google Scholar
• Jorat MV, Tabrizi R, Mirhosseini N, et al. The effects of coenzyme Q10 supplementation on lipid profiles among patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials. Lipids Health Dis. 2018;17(1):230. doi:10.1186/s12944-018-0876-430296936
   PubMed Web of Science ®Google Scholar